DE69535274D1 - Verwendung eines menschlichen interleukin-11 rezeptors - Google Patents

Verwendung eines menschlichen interleukin-11 rezeptors

Info

Publication number
DE69535274D1
DE69535274D1 DE69535274T DE69535274T DE69535274D1 DE 69535274 D1 DE69535274 D1 DE 69535274D1 DE 69535274 T DE69535274 T DE 69535274T DE 69535274 T DE69535274 T DE 69535274T DE 69535274 D1 DE69535274 D1 DE 69535274D1
Authority
DE
Germany
Prior art keywords
receptor
human interleukin
human
disclosed
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69535274T
Other languages
English (en)
Other versions
DE69535274T2 (de
Inventor
James F Tobin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genetics Institute LLC
Original Assignee
Genetics Institute LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genetics Institute LLC filed Critical Genetics Institute LLC
Publication of DE69535274D1 publication Critical patent/DE69535274D1/de
Application granted granted Critical
Publication of DE69535274T2 publication Critical patent/DE69535274T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C07K14/7155—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/02—Screening involving studying the effect of compounds C on the interaction between interacting molecules A and B (e.g. A = enzyme and B = substrate for A, or A = receptor and B = ligand for the receptor)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Hematology (AREA)
  • Reproductive Health (AREA)
  • Virology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE69535274T 1994-12-22 1995-11-27 Verwendung eines menschlichen interleukin-11 rezeptors Expired - Fee Related DE69535274T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US36230494A 1994-12-22 1994-12-22
US362304 1994-12-22
PCT/US1995/015400 WO1996019574A1 (en) 1994-12-22 1995-11-27 Human interleukin-11 receptor

Publications (2)

Publication Number Publication Date
DE69535274D1 true DE69535274D1 (de) 2006-11-30
DE69535274T2 DE69535274T2 (de) 2007-06-06

Family

ID=23425547

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69535274T Expired - Fee Related DE69535274T2 (de) 1994-12-22 1995-11-27 Verwendung eines menschlichen interleukin-11 rezeptors

Country Status (10)

Country Link
US (2) US6528281B1 (de)
EP (2) EP0797664B1 (de)
JP (2) JPH10511266A (de)
AT (1) ATE342970T1 (de)
AU (1) AU717928B2 (de)
CA (1) CA2208457A1 (de)
DE (1) DE69535274T2 (de)
DK (1) DK0797664T3 (de)
ES (1) ES2275268T3 (de)
WO (1) WO1996019574A1 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3949715B2 (ja) 1994-09-05 2007-07-25 アムラド・オペレイションズ・プロプライエタリー・リミテッド 新規ヘモポイエチン受容体
CA2237915A1 (en) * 1998-05-19 1999-11-19 Stephen Shaughnessy Osteoporosis treatment
US6953777B2 (en) 1999-03-11 2005-10-11 Genetics Indtitute LLC Use of interleukin-11 to prevent immune-mediated cytotoxicity
US7452964B2 (en) 2001-09-07 2008-11-18 Board Of Regents, The University Of Texas System Compositions and methods of use of targeting peptides against placenta and adipose tissues
US20040170955A1 (en) * 2000-09-08 2004-09-02 Wadih Arap Human and mouse targeting peptides identified by phage display
US7420030B2 (en) 2000-09-08 2008-09-02 The Board Of Regents Of The University Of Texas System Aminopeptidase A (APA) targeting peptides for the treatment of cancer
US20050074747A1 (en) * 2000-09-08 2005-04-07 Wadih Arap Biopanning and rapid analysis of selective interactive ligands (brasil)
CA2454357A1 (en) * 2001-07-18 2003-01-30 Wadih Arap An anti-angiogenic state in mice and humans with retinal photoreceptor cell degeneration
US8507445B2 (en) * 2001-09-07 2013-08-13 Board Of Regents, The University Of Texas System Compositions and methods of use of targeting peptides for diagnosis and therapy of human cancer
US20040048243A1 (en) * 2001-09-07 2004-03-11 Wadih Arap Methods and compositions for in vitro targeting
US7671010B2 (en) * 2002-08-30 2010-03-02 The Board Of Regents Of The University Of Texas System Compositions and methods of use of targeting peptides for diagnosis and therapy of human cancer
US6982080B2 (en) 2002-03-15 2006-01-03 Wyeth Hydroxyethyl starch—containing polypeptide compositions
WO2005065418A2 (en) * 2003-12-31 2005-07-21 Board Of Regents, The University Of Texas System Compositions and methods of use of targeting peptides for diagnosis and therapy
EP1598364A1 (de) * 2004-05-21 2005-11-23 AGIRx Limited Chimerischer löslicher Hyper IL-11 Rezeptor und dessen Verwendung
CA2898618A1 (en) * 2013-02-07 2014-08-14 Csl Limited Il-11r binding proteins and uses thereof
JP6959274B2 (ja) * 2013-02-07 2021-11-02 シーエスエル、リミテッド Ｉｌ−１１ｒ結合タンパク質及びその使用
GB201522186D0 (en) 2015-12-16 2016-01-27 Singapore Health Services Pte Ltd And Nat University Of Singapore The Treatment of fibrosis
GB201621439D0 (en) 2016-12-16 2017-02-01 Singapore Health Services Pte Ltd And Nat Univ Of Singapore IL-11Ra Antibodies
AU2017378111A1 (en) 2016-12-16 2019-06-13 National University Of Singapore IL-11 antibodies
GB201621431D0 (en) * 2016-12-16 2017-02-01 Singapore Health Services Pte Ltd And Nat Univ Of Singapore The Decoy cytokine receptor
MX2021008727A (es) 2019-01-21 2021-11-04 Singapore Health Serv Pte Ltd Tratamiento de la hepatotoxicidad.
US20210038584A1 (en) * 2019-08-05 2021-02-11 Novocure Gmbh Increasing Cancer Cells' Sensitivity to Tumor Treating Fields (TTFields) by Inhibiting IL11 Activity

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5215895A (en) 1989-11-22 1993-06-01 Genetics Institute, Inc. Dna encoding a mammalian cytokine, interleukin-11
US5292646A (en) 1991-02-06 1994-03-08 Genetics Institute, Inc. Peptide and protein fusions to thioredoxin and thioredoxin-like molecules
US5270181A (en) 1991-02-06 1993-12-14 Genetics Institute, Inc. Peptide and protein fusions to thioredoxin and thioredoxin-like molecules
JP3949715B2 (ja) * 1994-09-05 2007-07-25 アムラド・オペレイションズ・プロプライエタリー・リミテッド 新規ヘモポイエチン受容体

Also Published As

Publication number Publication date
DK0797664T3 (da) 2007-01-22
MX9704618A (es) 1997-09-30
EP1566440A2 (de) 2005-08-24
JP2006246890A (ja) 2006-09-21
DE69535274T2 (de) 2007-06-06
EP0797664A1 (de) 1997-10-01
AU717928B2 (en) 2000-04-06
JPH10511266A (ja) 1998-11-04
ES2275268T3 (es) 2007-06-01
AU4410096A (en) 1996-07-10
ATE342970T1 (de) 2006-11-15
US6528281B1 (en) 2003-03-04
EP0797664B1 (de) 2006-10-18
EP1566440A3 (de) 2005-10-19
WO1996019574A1 (en) 1996-06-27
CA2208457A1 (en) 1996-06-27
US6350855B1 (en) 2002-02-26

Similar Documents

Publication Publication Date Title
DE69535274D1 (de) Verwendung eines menschlichen interleukin-11 rezeptors
DK0939767T3 (da) Procin faktor VIII og hybrider deraf
DE69401230D1 (de) Verwendung von Polyurethanen, die funktionelle Carboxylatogruppe enthalt, zur Haarfestigung
ATE463502T1 (de) Menschliche toll-homologe
ATE222774T1 (de) Antikörper gegen cd 18 zur verwendung gegen gehirnschlag
DE69429482D1 (de) Methode und Einrichtung zur Datenkompression
DE69017849D1 (de) Rechnergestütztes Verfahren und System zur Verifikation und Überwachung von Lagerbeständen.
DE59103362D1 (de) Implantat für eine osteosynthesevorrichtung, insbesondere zur wirbelsäulenkorrektur.
DE69617484D1 (de) Vorrichtung zur Korrektur von eingewachsenen Nägeln
DE69840203D1 (de) Vefahren zur Datenkompression
ATE342976T1 (de) Cytokinrezeptor-kette
DE69109809D1 (de) Vorrichtung zur Beseitigung von Blattwellungen.
DE69618436D1 (de) Vorrichtung zur Herstellung von Taschenschraubenfedern
DE69524008D1 (de) Vorrichtung zur optischen Aufzeichnung von Information
DE69119936D1 (de) Einrichtung zur Datenkompression
DK0845943T3 (da) Nye peptider afledt fra humant heat shock protein 60 til behandling af diabetes, sammensætninger, fremgangsmåder og kits
DE69634512D1 (de) Traf-inhibitoren
AU7237391A (en) Carrier-bound recombinant protein, process for producing it and its use as an immunogen and vaccine
DE69504959D1 (de) Humanisierte monoklonale antikörper gegen humanes interleukin - 4
DE69018394D1 (de) Bilddatenkompressionsverfahren und -vorrichtung.
DK217388D0 (da) 1,3-dioxaner og fremgangsmaade til fremstilling deraf
NZ333075A (en) isolated protein markers for use in diagnosing esophageal cancer
DE69012624D1 (de) Reines Histon H1 zur therapeutischen Verwendung.
WO1998049194A3 (en) Ras-like protein
FR2642545B1 (fr) Appareil de controle de documents d'identite

Legal Events

Date Code Title Description
8339 Ceased/non-payment of the annual fee